Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Paliperidone in PTSD
NCT00766064Phase 4Withdrawn
- Sponsor
- Yale University
- Start
- Sep 2008
- Primary completion
- Nov 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of paliperidone in post-traumatic stress disorder (PTSD), sponsored by Yale University. Planned start Sep 2008; status: withdrawn.
02
Drugs
paliperidone
03
Conditions
post-traumatic stress disorder (PTSD)
Beyond the preview
Go deeper on NCT00766064.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00766064.